GEA GROUP
Explore by topic
5-year stock timeline
2021 (Feb–Dec)
Board extended CEO Stefan Klebert's contract through end-2026 and GEA launched "Mission 26" strategy following a year of operational improvement. FY 2021 showed order intake up 11%, EBITDA before restructuring of EUR 624.8m, and a proposed dividend increase to EUR 0.90. Share-buyback authorization was established [15], [1], [45].
Market perception shifted from restructuring story to profitable-growth and operational turnaround. Visible margin recovery drove investor interest, with the share price reaching a five-year high after 2021 performance [1].
Aug 16, 2021 – Dec 30, 2022
First share-buyback program (up to EUR 300m) executed in two tranches. By end-2022, GEA had repurchased 8,161,096 shares held as treasury shares, spending EUR 205.6m in the fiscal year [3], [38].
Buyback was read as clear capital-return commitment and proof of cash-generation, reinforcing confidence in EPS and ROCE improvement.
Mar 7, 2023 (FY 2022 results)
FY 2022 delivered order intake up 8.7% to EUR 5,678.9m, revenue up 9.8% to EUR 5,164.7m, and EBITDA before restructuring of EUR 712m (13.8% margin). Profit for the period reached EUR 401.4m, exceeding upgraded guidance [3].
Results validated the profitable-growth thesis and Mission 26 focus on margin and ROCE. Investors increasingly treated GEA as a quality industrial with improving profitability.
Nov 7, 2023
Executive Board resolved a new share-buyback program (up to EUR 400m) and decided that the 8,161,096 treasury shares from the 2021/22 program should be cancelled without reducing share capital [42], [43].
Aggressive capital-return and share-count reduction signalled management's focus on EPS accretion and capital efficiency, perceived as shareholder-friendly and valuation-positive.
Nov 9, 2023 – Dec 31, 2024
EUR 400m buyback program execution: by end-Dec 2024, GEA had repurchased 7,345,848 shares for EUR 284.3m at an average price of EUR 38.70 (shares to be cancelled at program end) [35].
Ongoing buybacks materially reduced the effective float and provided visible EPS support. Investor narrative moved toward margin compounding plus active capital allocation.
Mar 2024 (FY 2023 results)
FY 2023 delivered revenue of EUR 5,373.5m (organic growth +8.4%), EBITDA before restructuring of EUR 774.3m (14.4% margin), and order backlog of approximately EUR 3.1bn with continued ROCE expansion. Company reiterated margin improvement guidance [26], [23].
Despite macro pressure, GEA delivered margin expansion and cash conversion. Market increasingly viewed GEA as a resilient, high-quality industrial compounder.
Apr 11–14, 2025
GEA announced successful completion of the EUR 400m program with total repurchases of 9,529,412 shares between Nov 9, 2023 and Apr 11, 2025. Company proceeded with plans to cancel repurchased shares after the AGM, with repurchased shares representing approximately 5.5% of capital [36], [37].
Completion and planned cancellation crystallised the capital-return story with fewer shares outstanding and higher EPS and ROCE metrics. Market rewarded this with multiple expansion and higher market cap.
FY 2024 (reported / published 2025)
FY 2024 delivered revenue of EUR 5,422.1m, EBITDA before restructuring of EUR 837.3m (15.4% margin), and free cash flow of EUR 504.8m. Market capitalization rose noticeably at the reporting date [30].
The story consolidated into margin expansion plus strong free cash flow plus active buybacks equalling compounding returns. Investors treated GEA as a premium, cash-generative industrial with repeatable returns.
Early decision 2025 / effective 1 Jan 2026
Supervisory Board took an early decision to extend Stefan Klebert's contract through end-Dec 2028 and resolved a reorganization and streamlining of the Executive Board effective 1 Jan 2026 [20].
Continuity at the top plus a streamlined executive structure was read as management stability and better execution capacity, supportive for investor confidence.
2026 (11 Jul)
Latest quoted share price for GEA is 60.1.
Price reflects cumulative effects of multi-year margin expansion, strong free-cash-flow generation, and two consecutive large buyback programs plus management continuity. Market perception: GEA as a value-creating, margin-led industrial compounder with extended multi-year uptrend elevated by buyback-driven float reduction and improved fundamentals [30], [36], [35].
Key risks and downside factors
GEA Group supplies process technology, separation and packaging systems to the food, beverage, dairy and pharmaceutical industries globally. The company competes across turnkey systems, components and aftermarket services. Its main publicly listed competitors are Alfa Laval, Andritz, Krones, Sulzer and Marel, while significant private competitors like Tetra Pak, Syntegon and KHS hold important positions in packaging and line integration. The business carries exposure to cyclical capital expenditure patterns in its end markets, alongside persistent margin pressure from both competitive intensity and input cost and supply chain volatility.
- Cyclical end-market exposure creates a structural vulnerability. When food, beverage, or pharmaceutical companies cut capital spending, new-equipment orders and revenue can contract sharply.
- Intense competition from both listed and private rivals creates margin and market-share pressure, forcing pricing concessions that erode profitability.
- Supply-chain disruptions and commodity volatility—steel, electronics, components—create a dual pressure: delayed deliveries and climbing input costs. When these tighten simultaneously, margins compress faster than most forecasts capture.
- Regulatory, quality, and integration risk encompass strict food and pharma safety requirements, product liability and warranty exposure, and the execution risks inherent in acquisitions and integrations—each capable of triggering fines, recalls, or project delays.
Competitive landscape
GEA Group supplies process technology, equipment and turnkey systems to food, beverage, dairy and pharmaceutical manufacturers globally. Its competitive set spans separation, heat transfer, filling/packaging and plant integration—where it faces listed rivals including Alfa Laval, Andritz and Krones, alongside private competitors like Tetra Pak and Bühler in overlapping segments. The company's risk profile turns on three structural tensions. First, the execution burden of complex, integrated projects where delays or technical missteps compound quickly. Second, persistent margin compression from capable competitors and lower-cost entrants eroding pricing power. Third, the cyclical nature of capex spending in its end markets, which can create lumpy revenue and earnings volatility. Layered on top are the usual headwinds—supply chain friction, commodity exposure, currency swings and regulatory change—that affect capital equipment suppliers disproportionately.
| Company | Ticker |
|---|---|
| Alfa Laval AB | ALFA.ST |
| Krones AG | KRN.XETRA |
Private competitors
- Tetra Pak (Tetra Laval Group)
- Bühler Group
Get More Stock Analyses Like This
Receive hand-picked stock recommendations with detailed analyses every week
Start Free TrialPerformance Figures of GEA GROUP
Relative Performance vs Benchmarks
| Period | GEA GROUP | vs DAX | vs S&P 500 (SPY) |
|---|---|---|---|
| 1M | +9.97% | +6.43% | +7.38% |
| 3M | -1.29% | -6.60% | -12.69% |
| 6M | +1.49% | +2.82% | -7.69% |
| 1Y | +4.24% | +0.89% | -18.16% |
| 3Y | +72.32% | +15.88% | -3.38% |
| 5Y | +90.08% | +31.33% | +5.27% |
Get More Stock Analyses Like This
Receive hand-picked stock recommendations with detailed analyses every week
Start Free TrialHistorical valuation trends
How the company’s key valuation ratios (P/E, P/S, P/B and P/CF) have evolved over time compared to today.
| Period | P/E Ratio | P/S Ratio | P/B Ratio | P/CF Ratio |
|---|---|---|---|---|
| Current | 23.4 | 1.8 | 3.8 | 15.8 |
| 1Y ago | 24.4 | 1.8 | 4.1 | 13.8 |
| 3Y ago | 14.6 | 1.2 | 2.8 | 15.3 |
| 5Y ago | 40.7 | 1.4 | 3.2 | 9.6 |
Frequently Asked Questions
Where is the GEA GROUP stock traded?
What does GEA GROUP do?
What are the key metrics for G1A.XETRA?
How has GEA GROUP's stock price performed?
How is G1A.XETRA valued?
Does G1A.XETRA pay dividends?
What are the key risks when investing in G1A.XETRA?
- Cyclical end-market exposure creates a structural vulnerability. When food, beverage, or pharmaceutical companies cut capital spending, new-equipment orders and revenue can contract sharply.
- Intense competition from both listed and private rivals creates margin and market-share pressure, forcing pricing concessions that erode profitability.
- Supply-chain disruptions and commodity volatility—steel, electronics, components—create a dual pressure: delayed deliveries and climbing input costs. When these tighten simultaneously, margins compress faster than most forecasts capture.
- Regulatory, quality, and integration risk encompass strict food and pharma safety requirements, product liability and warranty exposure, and the execution risks inherent in acquisitions and integrations—each capable of triggering fines, recalls, or project delays.
Who are the main competitors of GEA GROUP?
- Alfa Laval AB (ALFA.ST)
- Krones AG (KRN.XETRA)
When does GEA GROUP report earnings?
Key Metrics
Valuation Metrics
Profitability Metrics
Growth Metrics
Dividend history
Long-term record of paid dividends (amount per share and dividend yield at the time of payment).
| Year | Dividend | Yield at payment | Avg. yield |
|---|---|---|---|
| 2026 | 1.30 EUR | 2.20% | 2.17% |
| 2025 | 1.15 EUR | 2.01% | |
| 2024 | 1.00 EUR | 2.64% | |
| 2023 | 0.95 EUR | 2.20% | |
| 2022 | 0.90 EUR | 2.40% | |
| 2021 | 0.85 EUR | 2.33% | |
| 2020 | 0.43 EUR | 1.48% | |
| 2020 | 0.42 EUR | 2.00% | |
| 2019 | 0.85 EUR | 3.34% | |
| 2018 | 0.85 EUR | 2.46% | |
| 2017 | 0.80 EUR | 2.07% | |
| 2016 | 0.80 EUR | 1.90% | |
| 2015 | 0.70 EUR | 1.53% | |
| 2014 | 0.60 EUR | 1.86% | |
| 2013 | 0.55 EUR | 2.16% |
Earnings history & estimates
Historical earnings performance shows how consistently the company meets or exceeds analyst expectations. Forward estimates provide insight into expected profitability and growth trajectory.
Historical earnings performance
Upcoming earnings report
Analyst estimates for upcoming periods
Key financial figures
Selected income statement, balance sheet and cash flow figures. Annual and quarterly, based on reported IFRS/GAAP financials.
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | 5.50B | 5.42B | 5.37B | 5.16B | 4.70B |
| Operating income (EBIT) | 639.78M | 593.03M | 504.90M | 466.88M | 380.90M |
| Net income | 414.01M | 385.04M | 392.76M | 401.43M | 305.17M |
| Free cash flow | 472.94M | 473.01M | 305.21M | 265.53M | 552.15M |
| Total assets | 6.09B | 6.03B | 5.95B | 5.92B | 5.87B |
| Equity | 2.45B | 2.42B | 2.40B | 2.28B | 2.08B |
| Net debt | -378.94M | -326.14M | -367.19M | -329.97M | -499.66M |
PWP Leeway UG (haftungsbeschränkt)
